{"id":5080,"date":"2018-01-19T14:44:03","date_gmt":"2018-01-19T13:44:03","guid":{"rendered":"http:\/\/trigenotoul.com\/?p=5080"},"modified":"2018-01-19T14:44:03","modified_gmt":"2018-01-19T13:44:03","slug":"roche-partnership-in-medical-imaging-supporting-cancer-immunotherapy","status":"publish","type":"post","link":"https:\/\/trigenotoul.com\/en\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/","title":{"rendered":"ROCHE Partnership: Imaging supporting cancer immunotherapy"},"content":{"rendered":"<h5 style=\"text-align: justify;\">The pharmaceutical company Roche and the Institute of Pharmacology and Structural Biology (IPBS) share the objective of developing strategies to combat cancer. Whilst Roche is a major player in the development of immunotherapy strategies, IPBS's research work aims to identify and characterise new therapeutic targets in the field of cancer, using in particular the imaging resources of the TRI-Genotoul platform.<\/h5>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_5081\" aria-describedby=\"caption-attachment-5081\" style=\"width: 535px\" class=\"wp-caption alignright\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-5081\" src=\"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg\" alt=\"Intravital imaging\" width=\"535\" height=\"556\" \/><figcaption id=\"caption-attachment-5081\" class=\"wp-caption-text\">Lymph node visualised by intravital multiphoton microscopy (green: dendritic cells, red: CD8 T lymphocytes, blue: collagen)<\/figcaption><\/figure>\n<p style=\"text-align: justify;\">\u00ab\u00a0<em>This partnership is a unique opportunity for our institute to take a direct part in the development of new and promising cancer treatments\u00a0<\/em>\u00bbsaid Jean-Philippe Girard, Director of the IPBS.\u00ab\u00a0<em>Imaging technologies are currently revolutionising the way we explore the mechanisms involved in diseases<\/em>\u00a0\u00bb, remarks Antonio Peixoto, Scientific Manager of the TRI-Genotoul imaging platform at IPBS. \u00ab\u00a0<em>Within this partnership, he continues, we will develop unique imaging strategies to dissect the mechanisms of action and evaluate the efficacy of new anti-cancer immunotherapies\u00a0<\/em>\u00bb.<\/p>\n<p style=\"text-align: justify;\">\u00ab\u00a0<em>Roche is continually seeking new partnerships in order to identify promising innovations at the earliest possible stage. We believe that our unique expertise in in vivo imaging can help us take a decisive step forward in understanding the anti-cancer immunotherapies we are developing<\/em> \u00bbsaid Mario Perro, Head of the Preclinical Imaging team at <em>Roche Pharma Research &amp; Early Development<\/em>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Le laboratoire pharmaceutique Roche et l\u2019Institut de Pharmacologie et de Biologie Structurale (IPBS) partagent l&rsquo;objectif de d\u00e9velopper des strat\u00e9gies de lutte contre le cancer. Alors que Roche est un acteur majeur dans le d\u00e9veloppement de strat\u00e9gies d\u2019immunoth\u00e9rapie, les travaux de recherche de l\u2019IPBS visent \u00e0 identifier et caract\u00e9riser de nouvelles cibles th\u00e9rapeutiques dans le domaine [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5081,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5080","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Partenariat ROCHE : L&#039;imagerie en appui de l&#039;immunoth\u00e9rapie du cancer - TRI-Genotoul<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/trigenotoul.com\/en\/roche-partnership-in-medical-imaging-supporting-cancer-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Partenariat ROCHE : L&#039;imagerie en appui de l&#039;immunoth\u00e9rapie du cancer - TRI-Genotoul\" \/>\n<meta property=\"og:description\" content=\"Le laboratoire pharmaceutique Roche et l\u2019Institut de Pharmacologie et de Biologie Structurale (IPBS) partagent l&rsquo;objectif de d\u00e9velopper des strat\u00e9gies de lutte contre le cancer. Alors que Roche est un acteur majeur dans le d\u00e9veloppement de strat\u00e9gies d\u2019immunoth\u00e9rapie, les travaux de recherche de l\u2019IPBS visent \u00e0 identifier et caract\u00e9riser de nouvelles cibles th\u00e9rapeutiques dans le domaine [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/trigenotoul.com\/en\/roche-partnership-in-medical-imaging-supporting-cancer-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"TRI-Genotoul\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-19T13:44:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"730\" \/>\n\t<meta property=\"og:image:height\" content=\"730\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gesteve\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gesteve\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/\"},\"author\":{\"name\":\"gesteve\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#\\\/schema\\\/person\\\/71018a7e00cf92ab28949e5339a08591\"},\"headline\":\"Partenariat ROCHE : L&rsquo;imagerie en appui de l&rsquo;immunoth\u00e9rapie du cancer\",\"datePublished\":\"2018-01-19T13:44:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/\"},\"wordCount\":294,\"publisher\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/trigenotoul.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/noued-lymphatique-intravital-1.jpg\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/\",\"url\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/\",\"name\":\"Partenariat ROCHE : L'imagerie en appui de l'immunoth\u00e9rapie du cancer - TRI-Genotoul\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/trigenotoul.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/noued-lymphatique-intravital-1.jpg\",\"datePublished\":\"2018-01-19T13:44:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/trigenotoul.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/noued-lymphatique-intravital-1.jpg\",\"contentUrl\":\"https:\\\/\\\/trigenotoul.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/noued-lymphatique-intravital-1.jpg\",\"width\":730,\"height\":730},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/trigenotoul.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Partenariat ROCHE : L&rsquo;imagerie en appui de l&rsquo;immunoth\u00e9rapie du cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#website\",\"url\":\"https:\\\/\\\/trigenotoul.com\\\/\",\"name\":\"TRI-Genotoul\",\"description\":\"Imagerie, cytom\u00e9trie &amp; analyse de donn\u00e9es pour les sciences du vivant\",\"publisher\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/trigenotoul.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#organization\",\"name\":\"TRI-Genotoul\",\"url\":\"https:\\\/\\\/trigenotoul.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/trigenotoul.com\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/ImagerieTRI_logo-Q3-1.png\",\"contentUrl\":\"https:\\\/\\\/trigenotoul.com\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/ImagerieTRI_logo-Q3-1.png\",\"width\":1000,\"height\":273,\"caption\":\"TRI-Genotoul\"},\"image\":{\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/trigenotoul.com\\\/#\\\/schema\\\/person\\\/71018a7e00cf92ab28949e5339a08591\",\"name\":\"gesteve\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ff90361fbad07b87db6e94afed78c806805bda9f3278f580caffd3dfd7e27e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ff90361fbad07b87db6e94afed78c806805bda9f3278f580caffd3dfd7e27e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ff90361fbad07b87db6e94afed78c806805bda9f3278f580caffd3dfd7e27e9?s=96&d=mm&r=g\",\"caption\":\"gesteve\"},\"sameAs\":[\"https:\\\/\\\/trigenotoul.com\\\/newsite\"],\"url\":\"https:\\\/\\\/trigenotoul.com\\\/en\\\/author\\\/gesteve\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROCHE Partnership: Imaging in support of cancer immunotherapy - TRI-Genotoul","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/trigenotoul.com\/en\/roche-partnership-in-medical-imaging-supporting-cancer-immunotherapy\/","og_locale":"en_GB","og_type":"article","og_title":"Partenariat ROCHE : L'imagerie en appui de l'immunoth\u00e9rapie du cancer - TRI-Genotoul","og_description":"Le laboratoire pharmaceutique Roche et l\u2019Institut de Pharmacologie et de Biologie Structurale (IPBS) partagent l&rsquo;objectif de d\u00e9velopper des strat\u00e9gies de lutte contre le cancer. Alors que Roche est un acteur majeur dans le d\u00e9veloppement de strat\u00e9gies d\u2019immunoth\u00e9rapie, les travaux de recherche de l\u2019IPBS visent \u00e0 identifier et caract\u00e9riser de nouvelles cibles th\u00e9rapeutiques dans le domaine [&hellip;]","og_url":"https:\/\/trigenotoul.com\/en\/roche-partnership-in-medical-imaging-supporting-cancer-immunotherapy\/","og_site_name":"TRI-Genotoul","article_published_time":"2018-01-19T13:44:03+00:00","og_image":[{"width":730,"height":730,"url":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg","type":"image\/jpeg"}],"author":"gesteve","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gesteve","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#article","isPartOf":{"@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/"},"author":{"name":"gesteve","@id":"https:\/\/trigenotoul.com\/#\/schema\/person\/71018a7e00cf92ab28949e5339a08591"},"headline":"Partenariat ROCHE : L&rsquo;imagerie en appui de l&rsquo;immunoth\u00e9rapie du cancer","datePublished":"2018-01-19T13:44:03+00:00","mainEntityOfPage":{"@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/"},"wordCount":294,"publisher":{"@id":"https:\/\/trigenotoul.com\/#organization"},"image":{"@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/","url":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/","name":"ROCHE Partnership: Imaging in support of cancer immunotherapy - TRI-Genotoul","isPartOf":{"@id":"https:\/\/trigenotoul.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#primaryimage"},"image":{"@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg","datePublished":"2018-01-19T13:44:03+00:00","breadcrumb":{"@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#primaryimage","url":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg","contentUrl":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2018\/01\/noued-lymphatique-intravital-1.jpg","width":730,"height":730},{"@type":"BreadcrumbList","@id":"https:\/\/trigenotoul.com\/partenariat-roche-limagerie-en-appui-de-limmunotherapie-du-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/trigenotoul.com\/"},{"@type":"ListItem","position":2,"name":"Partenariat ROCHE : L&rsquo;imagerie en appui de l&rsquo;immunoth\u00e9rapie du cancer"}]},{"@type":"WebSite","@id":"https:\/\/trigenotoul.com\/#website","url":"https:\/\/trigenotoul.com\/","name":"TRI-Genotoul","description":"Imaging, cytometry &amp; data analysis for the life sciences","publisher":{"@id":"https:\/\/trigenotoul.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/trigenotoul.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/trigenotoul.com\/#organization","name":"TRI-Genotoul","url":"https:\/\/trigenotoul.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/trigenotoul.com\/#\/schema\/logo\/image\/","url":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2017\/01\/ImagerieTRI_logo-Q3-1.png","contentUrl":"https:\/\/trigenotoul.com\/wp-content\/uploads\/2017\/01\/ImagerieTRI_logo-Q3-1.png","width":1000,"height":273,"caption":"TRI-Genotoul"},"image":{"@id":"https:\/\/trigenotoul.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/trigenotoul.com\/#\/schema\/person\/71018a7e00cf92ab28949e5339a08591","name":"gesteve","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/3ff90361fbad07b87db6e94afed78c806805bda9f3278f580caffd3dfd7e27e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ff90361fbad07b87db6e94afed78c806805bda9f3278f580caffd3dfd7e27e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ff90361fbad07b87db6e94afed78c806805bda9f3278f580caffd3dfd7e27e9?s=96&d=mm&r=g","caption":"gesteve"},"sameAs":["https:\/\/trigenotoul.com\/newsite"],"url":"https:\/\/trigenotoul.com\/en\/author\/gesteve\/"}]}},"_links":{"self":[{"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/posts\/5080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/comments?post=5080"}],"version-history":[{"count":0,"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/posts\/5080\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/media\/5081"}],"wp:attachment":[{"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/media?parent=5080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/categories?post=5080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trigenotoul.com\/en\/wp-json\/wp\/v2\/tags?post=5080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}